Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Clinical performance of a multimodal screening blood test for advanced adenomas and CRC in an average-risk cohort of 1,038 participants.
Authors
Shai Friedland
Stanford University Medical Center Gastroenterology and Hepatology, Stanford, CA;
Shai Friedland , Drew Watson , Douglas K. Rex , Ashish Nimgaonkar , Zhen Zhang , Alex Atkins , Ben Hsieh , Jr-Ming Lai , Stephen Su , Jen-chia Wu , Hung-Jen Shao , Jessica Tesoriero , Lindsey Hannah , John McGowan , Samir Gupta , John J. Sninsky , Rui Mei
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Prevention, Screening, and Hereditary Cancers
Clinical Trial Registration Number
NCT05127096
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 75)
DOI
10.1200/JCO.2023.41.4_suppl.75
Abstract #
75
Poster Bd #
D12
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Prevention of colorectal cancer through multiomics blood testing: The PREEMPT CRC study.
First Author: Girish Putcha
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Preferences for colorectal cancer screening of physicians and individuals at average risk in the United States: A discrete choice experiment.
First Author: Sebastian Heidenreich
Poster
2021 Gastrointestinal Cancers Symposium
Development and clinical validation of a blood test for early detection of colorectal adenomas and cancer.
First Author: Shai Friedland
Poster
2015 ASCO Annual Meeting
Risk factors for interval advanced colorectal neoplasia after screening colonoscopy.
First Author: Laura W. Musselwhite